{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:02:19Z","timestamp":1648742539277},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ancard.2011.04.008","type":"journal-article","created":{"date-parts":[[2011,6,23]],"date-time":"2011-06-23T18:41:04Z","timestamp":1308854464000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Hypertension art\u00e9rielle pulmonaire disproportionn\u00e9e\u00a0: caract\u00e9ristiques et pronostic d\u2019une cohorte de patients ni\u00e7ois r\u00e9f\u00e9r\u00e9s au laboratoire d\u2019\u00e9chocardiographie"],"prefix":"10.1016","volume":"61","author":[{"given":"T.","family":"Hugues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lemoigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Macone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cerboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gibelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ancard.2011.04.008_bib0005","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1183\/09031936.00015608","article-title":"Pulmonary hypertension in COPD","volume":"32","author":"Chaouat","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ancard.2011.04.008_bib0010","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1378\/chest.10-0087","article-title":"Pulmonary hypertension in COPD: epidemiology, significance and management: pulmonary vascular disease: the global perspective","volume":"137","author":"Minai","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ancard.2011.04.008_bib0015","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ancard.2011.04.008_bib0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.2107027","article-title":"Hemodynamic characterization of patients with severe emphysema","volume":"166","author":"Scharf","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ancard.2011.04.008_bib0025","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.27.4.594","article-title":"Report of an expert committee","volume":"27","year":"1963","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2011.04.008_bib0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/heart.89.2.225","article-title":"Chronic core pulmonale","volume":"89","author":"Weitzenblum","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.ancard.2011.04.008_bib0035","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/CIRCULATIONAHA.106.685206","article-title":"Pulmonary diseases and the heart","volume":"116","author":"Han","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2011.04.008_bib0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/ajrccm.164.2.2006129","article-title":"Natural history of pulmonary hypertension in a series of 131\u00a0patients with chronic obstructive lung disease","volume":"164","author":"Kessler","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ancard.2011.04.008_bib0045","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1136\/thx.36.10.752","article-title":"Pronostic value of pulmonary artery pressure in chronic obstructive pulmonary disease","volume":"36","author":"Weitzenblum","year":"1981","journal-title":"Thorax"},{"key":"10.1016\/j.ancard.2011.04.008_bib0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-93-3-391","article-title":"Continuous or nocturnal oxygen therapy in hyoxemic chronic obstructive lung disease","volume":"93","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ancard.2011.04.008_bib0055","first-page":"681","article-title":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema","volume":"1","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2011.04.008_bib0060","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1378\/chest.107.5.1193","article-title":"Prognostic factors in COPD patients receiving long term oxygen therapy. Importance of pulmonary artery pressure","volume":"107","author":"Oswald-Mammosser","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.ancard.2011.04.008_bib0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"Chaouat","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ancard.2011.04.008_bib0070","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1378\/chest.127.5.1480","article-title":"Severe pulmonary hypertension in COPD. Is it a distinct disease?","volume":"127","author":"Weitzenblum","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ancard.2011.04.008_bib0075","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1378\/chest.127.5.1531","article-title":"Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation","volume":"127","author":"Thabut","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ancard.2011.04.008_bib0080","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","article-title":"Pulmonary hypertension","volume":"351","author":"Farber","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2011.04.008_bib0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1164\/ajrccm.161.1.9807024","article-title":"Severe pulmonary hypertension in histiocytosis X","volume":"161","author":"Fartoukh","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ancard.2011.04.008_bib0090","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thx.2005.042838","article-title":"Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis","volume":"61","author":"Nunes","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.ancard.2011.04.008_bib0095","doi-asserted-by":"crossref","unstructured":"Horr A, Helman D, Davies D, Nathan S. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical chacteristics. Eur Respir J 2005;25:783\u201388.","DOI":"10.1183\/09031936.05.00083404"},{"issue":"2","key":"10.1016\/j.ancard.2011.04.008_bib0100","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/ajrccm.160.2.9810008","article-title":"Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis","volume":"160","author":"Olschewski","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ancard.2011.04.008_bib0105","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(02)11024-5","article-title":"Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial","volume":"360","author":"Ghofrani","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2011.04.008_bib0110","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1378\/chest.06-2101","article-title":"Sildenafil improves walk distance in idiopathic pulmonary fibrosis","volume":"131","author":"Collard","year":"2007","journal-title":"Chest"},{"issue":"Suppl. 3","key":"10.1016\/j.ancard.2011.04.008_bib0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2362.2006.01695.x","article-title":"Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease","volume":"36","author":"Ahmadi-Simab","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"10.1016\/j.ancard.2011.04.008_bib0120","first-page":"660","article-title":"A case of severe pulmonary hypertension associated with COPD treated with epoprostenol","volume":"46","author":"Ishikawa","year":"2008","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"issue":"1","key":"10.1016\/j.ancard.2011.04.008_bib0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.200705-732OC","article-title":"BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis","volume":"177","author":"King","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ancard.2011.04.008_bib0130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00011308","article-title":"A randomised, controlled trial of bosentan in severe COPD","volume":"32","author":"Stolz","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ancard.2011.04.008_bib0135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1164\/rccm.200907-0988OC","article-title":"Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension","volume":"181","author":"Blanco","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ancard.2011.04.008_bib0140","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1183\/09031936.00114207","article-title":"Sildenafil treatment in COPD does not affect stroke volume or exercice capacity","volume":"31","author":"Rietema","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ancard.2011.04.008_bib0145","series-title":"Pulmonary circulation: advances and controversies","article-title":"The heart in pulmonary hypertension due to chronic lung disease","author":"Morpugo","year":"1989"},{"key":"10.1016\/j.ancard.2011.04.008_bib0150","doi-asserted-by":"crossref","unstructured":"Naeieje R, Huez S. Right ventricular function in pulmonary hypertension: physiological concepts. Eur Hear J Suppl 2007;(9\u00a0suppl.):H5\u2013H9.","DOI":"10.1093\/eurheartj\/sum023"},{"key":"10.1016\/j.ancard.2011.04.008_bib0155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1513\/pats.200407-037MS","article-title":"Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease","volume":"2","author":"Naeije","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.ancard.2011.04.008_bib0160","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1183\/09031936.02.00245902","article-title":"Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD","volume":"19","author":"Santos","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ancard.2011.04.008_bib0165","doi-asserted-by":"crossref","unstructured":"Stolz D, Christ-Crain M, Morgenthaler NG, et al. Plasma pro-adrenomedullin but not plasma pro-endothelin predict survival in exacerbations of COPD. Chest 2008;134:263\u201372.","DOI":"10.1378\/chest.08-0047"},{"key":"10.1016\/j.ancard.2011.04.008_bib0170","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin\u00a01\u00a0in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2011.04.008_bib0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardiores.2003.11.026","article-title":"The endothelin system in pulmonary arterial hypertension","volume":"61","author":"Gali\u00e9","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ancard.2011.04.008_bib0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1139\/Y08-059","article-title":"Endothelin: 20\u00a0years from discovery to therapy","volume":"86","author":"Barton","year":"2008","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.ancard.2011.04.008_bib0185","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJM199105303242203","article-title":"Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease","volume":"324","author":"Dinh-Xuan","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2011.04.008_bib0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2466-8-20","article-title":"Exhaled and arterial levels of endothelin-1\u00a0are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension","volume":"8","author":"Carratu","year":"2008","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ancard.2011.04.008_bib0195","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1161\/01.CIR.0000091409.53101.E8","article-title":"Polymorphism of serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease","volume":"108","author":"Eddahibi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2011.04.008_bib0200","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1513\/pats.200603-038MS","article-title":"Interleukin-6\u00a0gene polymorphysm confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease","volume":"3","author":"Eddahibi","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.ancard.2011.04.008_bib0205","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1172\/JCI8678","article-title":"Attenued hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene","volume":"105","author":"Eddahibi","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ancard.2011.04.008_bib0210","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI200112805","article-title":"Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension","volume":"108","author":"Eddahibi","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ancard.2011.04.008_bib0215","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1183\/09031936.00091908","article-title":"Treating pulmonary hypertension in COPD: where do we start?","volume":"32","author":"Hoeper","year":"2008","journal-title":"Eur Respir J"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392811000862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392811000862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T02:55:07Z","timestamp":1543719307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392811000862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0003392811000862"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2011.04.008","relation":{},"ISSN":["0003-3928"],"issn-type":[{"value":"0003-3928","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}